speb/financial-data huggingface dataset:
APN.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -53660.00
APN.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 1538031.00
APN.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 111707.00
APN.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4286544.00
APN.V income_statement (quarterly, 2025-09-30) — Interest Expense: 9458.00
APN.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 9458.00
APN.V balance_sheet (quarterly, 2025-09-30) — Inventory: 25795.00
APN.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 750411.00
APN.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
APN.V balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 313.00
APN.V balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 313.00
APN.V cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
APN.V cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 40000.00
APN.V balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 636968.00
APN.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 40000.00
APN.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -12852.00
APN.V balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 185489.00
APN.V balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 3649576.00
APN.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
APN.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 756856.00
APN.V cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 134304.00
APN.V income_statement (quarterly, 2025-09-30) — Net Income: -881964.00
APN.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -881964.00
APN.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -881964.00
APN.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -881964.00
APN.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -881964.00
APN.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -881964.00
APN.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -881964.00
APN.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -9458.00
APN.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 27148.00
APN.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 27148.00
APN.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -9458.00
APN.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
APN.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 4286544.00
APN.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
APN.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -12676.00
APN.V balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 10546.00
APN.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -754216.00
APN.V income_statement (quarterly, 2025-09-30) — Normalized Income: -828304.00
APN.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -40834.00
APN.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 134304.00
APN.V income_statement (quarterly, 2025-09-30) — Operating Income: -818846.00
APN.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 361648.00
APN.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 156367544.00
APN.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 249385.00
APN.V balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 1538031.00
APN.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 56794.00
APN.V income_statement (quarterly, 2025-09-30) — Other Gand A: 111707.00
APN.V income_statement (quarterly, 2025-09-30) — Other Income Expense: -53660.00
APN.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 31541.00
APN.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1068787.00
APN.V balance_sheet (quarterly, 2025-09-30) — Other Payable: 682068.00
APN.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 21382.00
APN.V balance_sheet (quarterly, 2025-09-30) — Payables: 2484183.00
APN.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3366846.00
APN.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 172310.00
APN.V income_statement (quarterly, 2025-09-30) — Pretax Income: -881964.00
APN.V cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
APN.V balance_sheet (quarterly, 2025-09-30) — Receivables: 169203.00
APN.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 64630.00
APN.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -12852.00
APN.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -23808408.00
APN.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 111707.00
APN.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 156367544.00
APN.V income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
APN.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -12676.00
APN.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -12676.00
APN.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
APN.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
APN.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 13156.00
APN.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 4670942.00
APN.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -12676.00
APN.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 1131283.00
APN.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -12676.00
APN.V income_statement (quarterly, 2025-09-30) — Total Expenses: 1180494.00
APN.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4683618.00
APN.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4297403.00
APN.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 185489.00
APN.V balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 125541.00
APN.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: -53660.00
APN.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -53660.00
APN.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -4124590.00
APN.V income_statement (quarterly, 2025-09-30) — Write Off: 0.00
APN.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 606289.00
APN.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 161968.00
APN.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1770528.00
APN.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 80444.00
APN.V cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 930.00
APN.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 159162397.00
APN.V income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
APN.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 6231.00
APN.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 377250.00
APN.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 23259748.00
APN.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 98329.00
APN.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 98329.00
APN.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 98329.00
APN.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 196328.00
APN.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 153615.00
APN.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -616074.00
APN.V cash_flow (quarterly, 2025-12-31) — Change In Inventory: -1432.00
APN.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 8728.00
APN.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -106487.00
APN.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -99191.00
APN.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -61481.00
APN.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 92605.00
APN.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 23259748.00
APN.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 591173.00
APN.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 722341.00
APN.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 470537.00
APN.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 580688.00
APN.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 377250.00
APN.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 273868.00
APN.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 651118.00
APN.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4034692.00
APN.V balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 117228.00
APN.V cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -97327.00
APN.V cash_flow (quarterly, 2025-12-31) — Deferred Tax: -97327.00
APN.V cash_flow (quarterly, 2025-12-31) — Depreciation: 49114.00
APN.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 49114.00
APN.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 49114.00
APN.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 159162397.00
APN.V income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
APN.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -534658.00
APN.V income_statement (quarterly, 2025-12-31) — EBIT: -490655.00
APN.V income_statement (quarterly, 2025-12-31) — EBITDA: -441541.00
APN.V cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -507.00
APN.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 98329.00
APN.V balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 313.00
APN.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 532828.00
APN.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -593838.00
APN.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 0.00
APN.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -45404.00
APN.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1625697.00
APN.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 74805.00
APN.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4254936.00
APN.V income_statement (quarterly, 2025-12-31) — Interest Expense: 52003.00
APN.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 52003.00
APN.V balance_sheet (quarterly, 2025-12-31) — Inventory: 27227.00
APN.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 865041.00
APN.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 153615.00
APN.V balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 313.00
APN.V balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 313.00
APN.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 722341.00
APN.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -40000.00
APN.V balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 645071.00
APN.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -40000.00
APN.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -486013.00
APN.V balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 187973.00
APN.V balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3609865.00
APN.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 722341.00
APN.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 175539.00
APN.V cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 38962.00
APN.V income_statement (quarterly, 2025-12-31) — Net Income: -534658.00
APN.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -534658.00
APN.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -542658.00
APN.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -534658.00
APN.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -534658.00
APN.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -534658.00
APN.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -542658.00
APN.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -52003.00
APN.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -526013.00
APN.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -526013.00
APN.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -52003.00
APN.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 336500.00
APN.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 4254936.00
APN.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 153615.00
APN.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 591173.00
APN.V balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 99811.00
APN.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -395207.00
APN.V income_statement (quarterly, 2025-12-31) — Normalized Income: -488324.00
APN.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -593838.00
APN.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 38962.00
APN.V income_statement (quarterly, 2025-12-31) — Operating Income: -444321.00
APN.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 161968.00
APN.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 177561844.00
APN.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 156640.00
APN.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1625697.00
APN.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 56794.00
APN.V income_statement (quarterly, 2025-12-31) — Other Gand A: 74805.00
APN.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -46334.00
APN.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 48332.00
APN.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 531484.00
APN.V balance_sheet (quarterly, 2025-12-31) — Other Payable: 1010521.00
APN.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 99145.00
APN.V balance_sheet (quarterly, 2025-12-31) — Payables: 2913037.00
APN.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3383574.00
APN.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 183045.00
APN.V income_statement (quarterly, 2025-12-31) — Pretax Income: -542658.00
APN.V balance_sheet (quarterly, 2025-12-31) — Receivables: 272087.00
APN.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 49114.00
APN.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -486013.00
APN.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -24351066.00
APN.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 74805.00
APN.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 177561844.00
APN.V income_statement (quarterly, 2025-12-31) — Special Income Charges: -930.00
APN.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 591173.00
APN.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 591173.00
APN.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
APN.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
APN.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 92498.00
APN.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 4813838.00
APN.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 591173.00
APN.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 651118.00
APN.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 591173.00
APN.V income_statement (quarterly, 2025-12-31) — Total Expenses: 606289.00
APN.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4222665.00
APN.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4355060.00
APN.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 187973.00
APN.V balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 131988.00
APN.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -46334.00
APN.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -46334.00
APN.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -3454004.00
APN.V income_statement (quarterly, 2025-12-31) — Write Off: 930.00
APO balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -130072000.00
APO cash_flow (annual, 2021-12-31) — Capital Expenditure: -64738000.00
APO balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 505206000.00
APO cash_flow (annual, 2021-12-31) — Change In Account Payable: 25072000.00
APO cash_flow (annual, 2021-12-31) — Change In Payable: 519930000.00
APO cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: 519930000.00
APO cash_flow (annual, 2021-12-31) — Change In Receivables: 28504000.00
APO cash_flow (annual, 2021-12-31) — Changes In Account Receivables: 995000.00
APO cash_flow (annual, 2021-12-31) — Common Stock Issuance: 1001000000.00
APO balance_sheet (annual, 2021-12-31) — Current Debt: 38000000.00
APO balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 38000000.00
APO cash_flow (annual, 2021-12-31) — Deferred Income Tax: 464726000.00
APO cash_flow (annual, 2021-12-31) — Deferred Tax: 464726000.00
APO cash_flow (annual, 2021-12-31) — Dividend Received Cfo: 2082944000.00
APO cash_flow (annual, 2021-12-31) — Dividends Received Cfi: 322791000.00
APO cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: -3699209000.00
APO balance_sheet (annual, 2021-12-31) — Employee Benefits: 0.00
APO cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -47601000.00
APO balance_sheet (annual, 2021-12-31) — Gross PPE: 706783000.00
APO balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 1687000000.00
APO balance_sheet (annual, 2021-12-31) — Line Of Credit: 38000000.00
APO balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 505206000.00
APO balance_sheet (annual, 2021-12-31) — Net Debt: 12308000000.00
APO balance_sheet (annual, 2021-12-31) — Net PPE: 576711000.00
APO cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -64738000.00
APO balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 424132000.00
APO balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
APO balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 14846000.00
APO balance_sheet (annual, 2021-12-31) — Other Properties: 706783000.00
APO income_statement (annual, 2021-12-31) — Other Special Charges: 3493380000.00
APO balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 1770000000.00
APO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 57765000.00
APO cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: -140630000.00
APO cash_flow (annual, 2021-12-31) — Purchase Of PPE: -64738000.00
APO cash_flow (annual, 2021-12-31) — Sale Of Investment: 3709451000.00
APO balance_sheet (annual, 2021-12-31) — Taxes Receivable: 30334000.00
APO income_statement (annual, 2021-12-31) — Total Other Finance Cost: -54000000.00
APO cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: -2586150000.00
APO income_statement (annual, 2022-12-31) — +Operating Expense: 14416000000.00
APO income_statement (annual, 2022-12-31) — +Total Revenue: 10968000000.00
APO balance_sheet (annual, 2022-12-31) — Accounts Payable: 2975000000.00
APO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -160654000.00
APO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 14982000000.00
APO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 1766000000.00
APO income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
APO income_statement (annual, 2022-12-31) — Basic Average Shares: 584691775.00
APO income_statement (annual, 2022-12-31) — Basic EPS: -3.43
APO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2088000000.00
APO cash_flow (annual, 2022-12-31) — Capital Expenditure: -202525000.00
APO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 664366000.00
APO balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
APO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 9452000000.00
APO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 127373000000.00
APO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -962000000.00
APO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 28710000000.00
APO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -23444000000.00
APO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 3789000000.00
APO cash_flow (annual, 2022-12-31) — Change In Account Payable: 22143000.00
APO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 3901000000.00
APO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 2044000000.00
APO cash_flow (annual, 2022-12-31) — Change In Payable: 80432000.00
APO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 80432000.00
APO cash_flow (annual, 2022-12-31) — Change In Receivables: -232757000.00
APO cash_flow (annual, 2022-12-31) — Change In Working Capital: 5945000000.00
APO cash_flow (annual, 2022-12-31) — Changes In Cash: 9055000000.00
APO balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
APO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -962000000.00
APO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 6640000000.00
APO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
APO cash_flow (annual, 2022-12-31) — Common Stock Payments: -635000000.00
APO income_statement (annual, 2022-12-31) — Cost Of Revenue: 927000000.00
APO balance_sheet (annual, 2022-12-31) — Current Assets: 133872000000.00
APO balance_sheet (annual, 2022-12-31) — Current Debt: 35000000.00
APO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 35000000.00
APO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 173616000000.00
APO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 173616000000.00
APO balance_sheet (annual, 2022-12-31) — Current Liabilities: 184331000000.00
APO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 107591000.00
APO cash_flow (annual, 2022-12-31) — Deferred Tax: 107591000.00
APO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 529000000.00
APO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 529000000.00
APO income_statement (annual, 2022-12-31) — Diluted Average Shares: 584691775.00
APO income_statement (annual, 2022-12-31) — Diluted EPS: -3.43
APO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2923000000.00
APO cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 97889000.00
APO balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 465000000.00
APO balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 998000000.00
APO income_statement (annual, 2022-12-31) — EBIT: -4025000000.00
APO income_statement (annual, 2022-12-31) — EBITDA: -3496000000.00
APO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -15000000.00
APO balance_sheet (annual, 2022-12-31) — Employee Benefits: 55328000000.00
APO cash_flow (annual, 2022-12-31) — End Cash Position: 11128000000.00
APO balance_sheet (annual, 2022-12-31) — Financial Assets: 3309000000.00
APO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 28710000000.00
APO cash_flow (annual, 2022-12-31) — Free Cash Flow: 3789000000.00
APO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 4429000000.00
APO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 258000000.00
APO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -7335000000.00
APO income_statement (annual, 2022-12-31) — General And Administrative Expense: 1698000000.00
APO balance_sheet (annual, 2022-12-31) — Goodwill: 4322000000.00
APO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4322000000.00
APO balance_sheet (annual, 2022-12-31) — Gross PPE: 1037797000.00
APO income_statement (annual, 2022-12-31) — Gross Profit: 10041000000.00
APO balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 709000000.00
APO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1007000000.00
APO income_statement (annual, 2022-12-31) — Interest Expense: 221000000.00
APO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 221000000.00
APO income_statement (annual, 2022-12-31) — Interest Income: 354000000.00
APO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 354000000.00
APO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 566000000.00
APO balance_sheet (annual, 2022-12-31) — Invested Capital: 13162000000.00
APO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -23444000000.00
APO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1766000000.00
APO balance_sheet (annual, 2022-12-31) — Investments And Advances: 98868000000.00
APO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
APO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 5745000000.00
APO balance_sheet (annual, 2022-12-31) — Line Of Credit: 35000000.00
APO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 664366000.00
APO balance_sheet (annual, 2022-12-31) — Long Term Debt: 6487000000.00
APO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 6487000000.00
APO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 5745000000.00
APO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -4033000000.00
APO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 979000000.00
APO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 42110000000.00
APO balance_sheet (annual, 2022-12-31) — Minority Interest: 8758000000.00
APO income_statement (annual, 2022-12-31) — Minority Interests: 1546000000.00
APO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 30303000000.00
APO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -635000000.00
APO balance_sheet (annual, 2022-12-31) — Net Debt: 1553794000.00
APO income_statement (annual, 2022-12-31) — Net Income: -1961000000.00
APO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2923000000.00
APO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -3507000000.00
APO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -1961000000.00
APO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -1961000000.00
APO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -3507000000.00
APO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -3507000000.00
APO income_statement (annual, 2022-12-31) — Net Interest Income: 277000000.00
APO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -63890000000.00
APO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1712000000.00
APO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1712000000.00
APO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 277000000.00
APO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 28595000000.00
APO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 10143000000.00
APO balance_sheet (annual, 2022-12-31) — Net PPE: 877143000.00
APO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -202525000.00
APO cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
APO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2318000000.00
APO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 4466000000.00
APO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 633660000.00
APO balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 55328000000.00
APO income_statement (annual, 2022-12-31) — Normalized EBITDA: -3310000000.00
APO income_statement (annual, 2022-12-31) — Normalized Income: -1807364000.00
APO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 3789000000.00
APO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 4429000000.00
APO income_statement (annual, 2022-12-31) — Operating Income: -4375000000.00
APO income_statement (annual, 2022-12-31) — Operating Revenue: 10996000000.00
APO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 570276188.00
APO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -7335000000.00
APO income_statement (annual, 2022-12-31) — Other Gand A: 682000000.00
APO income_statement (annual, 2022-12-31) — Other Income Expense: -148000000.00
APO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 179215000.00
APO balance_sheet (annual, 2022-12-31) — Other Investments: 96123000000.00
APO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -4147000000.00
APO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 12380000000.00
APO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 51001000000.00
APO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 38000000.00
APO income_statement (annual, 2022-12-31) — Other Operating Expenses: 12718000000.00
APO balance_sheet (annual, 2022-12-31) — Other Payable: 6707000000.00
APO balance_sheet (annual, 2022-12-31) — Other Properties: 1037797000.00
APO balance_sheet (annual, 2022-12-31) — Other Receivables: 4358000000.00
APO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 117921000000.00
APO income_statement (annual, 2022-12-31) — Other Special Charges: 1943189000.00
APO income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 962000000.00
APO balance_sheet (annual, 2022-12-31) — Payables: 10680000000.00
APO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 10680000000.00
APO balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 1032000000.00
APO balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 23000000.00
APO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
APO cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: 0.00
APO income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 36656000.00
APO balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 554213000.00
APO cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
APO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 62098000.00
APO income_statement (annual, 2022-12-31) — Pretax Income: -4246000000.00
APO cash_flow (annual, 2022-12-31) — Purchase Of Business: -3992000000.00
APO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -63890000000.00
APO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -202525000.00
APO balance_sheet (annual, 2022-12-31) — Receivables: 4823000000.00
APO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 927000000.00
APO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 529000000.00
APO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -4033000000.00
APO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -635000000.00
APO balance_sheet (annual, 2022-12-31) — Restricted Cash: 1676000000.00
APO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 444000000.00
APO balance_sheet (annual, 2022-12-31) — Retained Earnings: -1007000000.00
APO income_statement (annual, 2022-12-31) — Salaries And Wages: 1016000000.00
APO cash_flow (annual, 2022-12-31) — Sale Of Business: 34295000000.00
APO cash_flow (annual, 2022-12-31) — Sale Of Investment: 6086110000.00
APO income_statement (annual, 2022-12-31) — Selling General And Administration: 1698000000.00
APO balance_sheet (annual, 2022-12-31) — Share Issued: 570276188.00
APO income_statement (annual, 2022-12-31) — Special Income Charges: -444000000.00
APO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 540000000.00
APO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 6640000000.00
APO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2318000000.00
APO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -32364000.00
APO income_statement (annual, 2022-12-31) — Tax Provision: -739000000.00
APO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.17
APO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 92610000.00
APO balance_sheet (annual, 2022-12-31) — Total Assets: 257217000000.00
APO balance_sheet (annual, 2022-12-31) — Total Capitalization: 13127000000.00
APO balance_sheet (annual, 2022-12-31) — Total Debt: 6522000000.00
APO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 15398000000.00
APO income_statement (annual, 2022-12-31) — Total Expenses: 15343000000.00
APO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 241819000000.00
APO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 123345000000.00
APO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 57488000000.00
APO income_statement (annual, 2022-12-31) — Total Other Finance Cost: -144000000.00
APO income_statement (annual, 2022-12-31) — Total Unusual Items: -186000000.00
APO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -186000000.00
APO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 24522000.00
APO balance_sheet (annual, 2022-12-31) — Working Capital: -50459000000.00
APO income_statement (annual, 2023-12-31) — +Operating Expense: 25471000000.00
APO income_statement (annual, 2023-12-31) — +Total Revenue: 32644000000.00
APO balance_sheet (annual, 2023-12-31) — Accounts Payable: 3338000000.00
APO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 15249000000.00
APO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 1611000000.00
APO income_statement (annual, 2023-12-31) — Average Dilution Earnings: 41000000.00
APO income_statement (annual, 2023-12-31) — Basic Average Shares: 581000000.00
APO income_statement (annual, 2023-12-31) — Basic EPS: 8.53
APO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 11128000000.00
APO balance_sheet (annual, 2023-12-31) — Capital Stock: 1398000000.00
APO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 15928000000.00
APO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 170243000000.00
APO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1034000000.00
APO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 42638000000.00
APO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -42407000000.00
APO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 6322000000.00
APO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 4333000000.00
APO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -898000000.00
APO cash_flow (annual, 2023-12-31) — Change In Working Capital: 3435000000.00
APO cash_flow (annual, 2023-12-31) — Changes In Cash: 6553000000.00
APO balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
APO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -1012000000.00
APO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 12646000000.00
APO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
APO cash_flow (annual, 2023-12-31) — Common Stock Payments: -561000000.00
APO income_statement (annual, 2023-12-31) — Cost Of Revenue: 1027000000.00
APO balance_sheet (annual, 2023-12-31) — Current Assets: 176609000000.00
APO balance_sheet (annual, 2023-12-31) — Current Debt: 31000000.00
APO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 31000000.00
APO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 204670000000.00
APO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 204670000000.00
APO balance_sheet (annual, 2023-12-31) — Current Liabilities: 216445000000.00
APO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 803000000.00
APO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 803000000.00
APO income_statement (annual, 2023-12-31) — Diluted Average Shares: 589000000.00
APO income_statement (annual, 2023-12-31) — Diluted EPS: 8.49
APO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 3915000000.00
APO balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 449000000.00
APO balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 870000000.00
APO income_statement (annual, 2023-12-31) — EBIT: 5844000000.00
APO income_statement (annual, 2023-12-31) — EBITDA: 6647000000.00
APO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 10000000.00
APO cash_flow (annual, 2023-12-31) — End Cash Position: 17691000000.00
APO balance_sheet (annual, 2023-12-31) — Financial Assets: 5298000000.00
APO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 42638000000.00
APO cash_flow (annual, 2023-12-31) — Free Cash Flow: 6322000000.00
APO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -3213000000.00
APO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 74000000.00
APO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -5575000000.00
APO income_statement (annual, 2023-12-31) — General And Administrative Expense: 2567000000.00
APO balance_sheet (annual, 2023-12-31) — Goodwill: 4329000000.00
APO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 4329000000.00
APO income_statement (annual, 2023-12-31) — Gross Profit: 31617000000.00
APO balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 0.00
APO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 358000000.00
APO income_statement (annual, 2023-12-31) — Interest Expense: 258000000.00
APO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 258000000.00
APO income_statement (annual, 2023-12-31) — Interest Income: 176000000.00
APO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 176000000.00
APO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 720000000.00
APO balance_sheet (annual, 2023-12-31) — Invested Capital: 20738000000.00
APO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -42407000000.00
APO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1611000000.00
APO balance_sheet (annual, 2023-12-31) — Investments And Advances: 106702000000.00
APO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 1398000000.00
APO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 4912000000.00
APO balance_sheet (annual, 2023-12-31) — Line Of Credit: 31000000.00
APO balance_sheet (annual, 2023-12-31) — Long Term Debt: 8061000000.00
APO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 8061000000.00
APO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 4912000000.00
APO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3780000000.00
APO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1072000000.00
APO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 53287000000.00
APO balance_sheet (annual, 2023-12-31) — Minority Interest: 11201000000.00
APO income_statement (annual, 2023-12-31) — Minority Interests: -1462000000.00
APO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 24402000000.00
APO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -561000000.00
APO income_statement (annual, 2023-12-31) — Net Income: 5047000000.00
APO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 3874000000.00
APO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 6509000000.00
APO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 5047000000.00
APO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 5047000000.00
APO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 6509000000.00
APO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 6509000000.00
APO income_statement (annual, 2023-12-31) — Net Interest Income: -82000000.00
APO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -67040000000.00
APO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 1132000000.00
APO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 1132000000.00
APO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -82000000.00
APO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 41703000000.00
APO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 231000000.00
APO cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 1398000000.00
APO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 9715000000.00
APO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 5979000000.00
APO income_statement (annual, 2023-12-31) — Normalized EBITDA: 7261000000.00
APO income_statement (annual, 2023-12-31) — Normalized Income: 5532060000.00
APO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 6322000000.00
APO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -3213000000.00
APO income_statement (annual, 2023-12-31) — Operating Income: 6146000000.00
APO income_statement (annual, 2023-12-31) — Operating Revenue: 32053000000.00
APO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 567762932.00
APO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -5575000000.00
APO income_statement (annual, 2023-12-31) — Other Gand A: 872000000.00
APO income_statement (annual, 2023-12-31) — Other Income Expense: -478000000.00
APO balance_sheet (annual, 2023-12-31) — Other Investments: 104019000000.00
APO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -2238000000.00
APO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 14571000000.00
APO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 63737000000.00
APO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 136000000.00
APO income_statement (annual, 2023-12-31) — Other Operating Expenses: 22904000000.00
APO balance_sheet (annual, 2023-12-31) — Other Payable: 7536000000.00
APO balance_sheet (annual, 2023-12-31) — Other Receivables: 4154000000.00
APO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 154315000000.00
APO income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 1127000000.00
APO balance_sheet (annual, 2023-12-31) — Payables: 11744000000.00
APO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 11744000000.00
APO balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 28749765.00
APO balance_sheet (annual, 2023-12-31) — Preferred Stock: 1398000000.00
APO cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -22000000.00
APO income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 46000000.00
APO balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 1398000000.00
APO cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 1398000000.00
APO income_statement (annual, 2023-12-31) — Pretax Income: 5586000000.00
APO cash_flow (annual, 2023-12-31) — Purchase Of Business: -4650000000.00
APO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -67040000000.00
APO balance_sheet (annual, 2023-12-31) — Receivables: 4603000000.00
APO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1027000000.00
APO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 803000000.00
APO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -3780000000.00
APO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -561000000.00
APO balance_sheet (annual, 2023-12-31) — Restricted Cash: 1763000000.00
APO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 688000000.00
APO balance_sheet (annual, 2023-12-31) — Retained Earnings: 2972000000.00
APO income_statement (annual, 2023-12-31) — Salaries And Wages: 1695000000.00
APO cash_flow (annual, 2023-12-31) — Sale Of Business: 29052000000.00
APO income_statement (annual, 2023-12-31) — Selling General And Administration: 2567000000.00
APO balance_sheet (annual, 2023-12-31) — Share Issued: 567762932.00
APO income_statement (annual, 2023-12-31) — Special Income Charges: -688000000.00
APO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1026000000.00
APO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 14044000000.00
APO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 8317000000.00
APO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -128940000.00
APO income_statement (annual, 2023-12-31) — Tax Provision: -923000000.00
APO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
APO balance_sheet (annual, 2023-12-31) — Total Assets: 313488000000.00
APO balance_sheet (annual, 2023-12-31) — Total Capitalization: 22105000000.00
APO balance_sheet (annual, 2023-12-31) — Total Debt: 8092000000.00
APO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 25245000000.00
APO income_statement (annual, 2023-12-31) — Total Expenses: 26498000000.00
APO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 288243000000.00
APO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 136879000000.00
APO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 71798000000.00
APO income_statement (annual, 2023-12-31) — Total Unusual Items: -614000000.00
APO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -614000000.00
APO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
APO balance_sheet (annual, 2023-12-31) — Working Capital: -39836000000.00
APO balance_sheet (quarterly, 2024-09-30) — Line Of Credit: 0.00
APO balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 52962000000.00
APO income_statement (annual, 2024-12-31) — +Operating Expense: 16675000000.00
APO income_statement (annual, 2024-12-31) — +Total Revenue: 26114000000.00
APO balance_sheet (annual, 2024-12-31) — Accounts Payable: 3616000000.00
APO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 15327000000.00
APO balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 1524000000.00
APO income_statement (annual, 2024-12-31) — Average Dilution Earnings: 97000000.00
APO income_statement (quarterly, 2024-12-31) — Average Dilution Earnings: 97000000.00
APO income_statement (annual, 2024-12-31) — Basic Average Shares: 586000000.00
APO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 584000000.00
APO income_statement (annual, 2024-12-31) — Basic EPS: 7.39
APO income_statement (quarterly, 2024-12-31) — Basic EPS: 2.42
APO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 17691000000.00
APO balance_sheet (annual, 2024-12-31) — Capital Stock: 1398000000.00
APO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 16166000000.00
APO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 205980000000.00
APO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1189000000.00
APO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 57972000000.00
APO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -61801000000.00
APO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 3253000000.00